New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1, (vol 78, pg 4610, 2010)

Samankaltaisia teoksia

• New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
  Tekijä: Goodman, A, et al.
  Julkaistu: (2010)
• EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
  Tekijä: Goodman, A, et al.
  Julkaistu: (2009)
• Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.
  Tekijä: de Cassan, S, et al.
  Julkaistu: (2013)
• Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
  Tekijä: Alcock, R, et al.
  Julkaistu: (2010)
• Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
  Tekijä: Draper, S, et al.
  Julkaistu: (2013)